Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies

Nature Microbiology

Volumn 3, Issue 4, 2018, Pages 514-522

  Tramontano, Melanie ^a   Andrejev, Sergej ^a   Pruteanu, Mihaela ^a,f   Klünemann, Martina ^a   Kuhn, Michael ^a   Galardini, Marco ^b   Jouhten, Paula ^a   Zelezniak, Aleksej ^a,g   Zeller, Georg ^a   Bork, Peer ^a,c,d,e   Typas, Athanasios ^a   Patil, Kiran Raosaheb ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d Molecular Medicine Partnership Unit   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f HUMBOLDT UNIVERSITY   (Germany)

^g CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; SHORT CHAIN FATTY ACID; MUCIN; VOLATILE FATTY ACID;

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; CONTROLLED STUDY; FOOD PREFERENCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; BACTERIUM; CHEMISTRY; CLASSIFICATION; CULTURE MEDIUM; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

AMINO ACIDS; BACTERIA; CULTURE MEDIA; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; MUCINS;

EID: 85043340868     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-018-0123-9     Document Type: Article

References (65)

1. Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
2. Sharon, G., Sampson, T. R., Geschwind, D. H. & Mazmanian, S. K. The central nervous system and the gut microbiome. Cell 167, 915-932 (2016).
3. Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1095 (2015).
4. Holmes, E., Li, J. V., Marchesi, J. R. & Nicholson, J. K. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16, 559-564 (2012).
5. Sonnenburg, J. L. & Bäckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56-64 (2016).
6. Luis, A. S. et al. Dietary pectic glycans are degraded by coordinated enzyme pathways in human colonic Bacteroides. Nat. Microbiol. 3, 210-219 (2017).
7. O'Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G. & Cryan, J. F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277, 32-48 (2015).
8. Bäumler, A. J. & Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85-93 (2016).
9. Pedersen, H. K. et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376-381 (2016).
10. Curtis, M. M. et al. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16, 759-769 (2014).
11. Neidhardt, F. C., Bloch, P. L. & Smith, D. F. Culture medium for enterobacteria. J. Bacteriol. 119, 736-747 (1974).
12. Goodman, A. L. et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6, 279-289 (2009).
13. Sebald, M. & Costilow, R. N. Minimal growth requirements for Clostridium perfringens and isolation of auxotrophic mutants. Appl. Microbiol. 29, 1-6 (1975).
14. Lopes, J. N. & Cruz, F. S. Chemically defined media for growing anaerobic bacteria of the genus Veillonella. Antonie Van. Leeuwenhoek 42, 411-420 (1976).
15. Magnúsdóttir, S. et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat. Biotechnol. 35, 81-89 (2017).
16. Larsbrink, J. et al. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 506, 498-502 (2014).
17. Ponomarova, O. & Patil, K. R. Metabolic interactions in microbial communities: untangling the Gordian knot. Curr. Opin. Microbiol. 27, 37-44 (2015).
18. Thiele, I. & Palsson, B. Ø. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93-121 (2010).
19. Shoaie, S. et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22, 320-331 (2015).
20. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
21. Strauss, J. et al. Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971-1978 (2011).
22. Grass, J. E., Gould, L. H. & Mahon, B. E. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998-2010. Foodborne Pathog. Dis. 10, 131-136 (2013).
23. Gardiner, B. J. et al. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J. Clin. Microbiol. 53, 626-635 (2015).
24. Könönen, E. & Wade, W. G. Actinomyces and related organisms in human infections. Clin. Microbiol. Rev. 28, 419-442 (2015).
25. Goodman, A. L. et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl Acad. Sci. USA 108, 6252-6257 (2011).
26. Zhang, G., Mills, D. A. & Block, D. E. Development of chemically defined media supporting high-cell-density growth of lactococci, enterococci, and streptococci. Appl. Environ. Microbiol. 75, 1080-1087 (2009).
27. Wegkamp, A., Van Oorschot, W., De Vos, W. M. & Smid, E. J. Characterization of the role of para-aminobenzoic acid biosynthesis in folate production by Lactococcus lactis. Appl. Environ. Microbiol. 73, 2673-2681 (2007).
28. Evans, D. F. et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29, 1035-1041 (1988).
29. Rettedal, E. A., Gumpert, H. & Sommer, M. O. A. Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat. Commun. 5, 4714 (2014).
30. Png, C. W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420-2428 (2010).
31. Klumpp, S., Zhang, Z. & Hwa, T. Growth rate-dependent global effects on gene expression in bacteria. Cell 139, 1366-1375 (2009).
32. Browne, H. P. et al. Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature 533, 543-546 (2016).
33. Ríos-Covián, D. et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 7, 185 (2016).
34. Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672 (2014).
35. Bergeim, O. Toxicity of intestinal volatile fatty acids for yeast and Esch. coli. J. Infect. Dis. 66, 222-234 (1940).
36. Hentges, D. J. Influence of pH on the inhibitory activity of formic and acetic acids for Shigella. J. Bacteriol. 93, 2029-2030 (1967).
37. De Felice, M., Levinthal, M., Iaccarino, M. & Guardiola, J. Growth inhibition as a consequence of antagonism between related amino acids: effect of valine in Escherichia coli K-12. Microbiol. Rev. 43, 42-58 (1979).
38. Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. https://doi.org/10.3389/fgene.2015.00081 (2015).
39. Ng, K. M. et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99 (2013).
40. Ponomarova, O. et al. Yeast creates a niche for symbiotic lactic acid bacteria through nitrogen overflow. Cell Syst. 5, 345-357 (2017).
41. Haft, D. H. et al. TIGRFAMs and genome properties in 2013. Nucleic Acids Res. 41, D387-D395 (2013).
42. Lau, J. T. et al. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome Med. 8, 72 (2016).
43. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature https://doi.org/10.1038/nature25979 (2018).
44. Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141-2146 (2002).
45. Buurman, E. T., Pennock, J., Tempest, D. W., Teixeira de Mattos, M. J. & Neijssel, O. M. Replacement of potassium ions by ammonium ions in different micro-organisms grown in potassium-limited chemostat culture. Arch. Microbiol. 152, 58-63 (1989).
46. Roe, A. J., O'Byrne, C., McLaggan, D. & Booth, I. R. Inhibition of Escherichia coli growth by acetic acid: a problem with methionine biosynthesis and homocysteine toxicity. Microbiology 148, 2215-2222 (2002).
47. Nava, G. M., Friedrichsen, H. J. & Stappenbeck, T. S. Spatial organization of intestinal microbiota in the mouse ascending colon. ISME J. 5, 627-638 (2011).
48. Sonnenburg, J. L. et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955-1959 (2005).
49. Crost, E. H. et al. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS ONE 8, e76341 (2013).
50. Mende, D. R., Sunagawa, S., Zeller, G. & Bork, P. Accurate and universal delineation of prokaryotic species. Nat. Methods 10, 881-884 (2013).
51. Huttenhower, C. et al. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
52. Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822-832 (2014).
53. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing: commentary. Nature 11, 28 (2010).
54. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
55. Chen, I. M. A. et al. IMG/M: Integrated genome and metagenome comparative data analysis system. Nucleic Acids Res. 45, 507-516 (2017).
56. Markowitz, V. M. et al. IMG/M 4 version of the integrated metagenome comparative analysis system. Nucleic Acids Res. 42, 568-573 (2014).
57. Topping, D. L. & Clifton, P. M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81, 1031-1064 (2001).
58. Cook, S. I. & Sellin, J. H. Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12, 499-507 (1998).
59. Massey, L. K., Sokatch, J. R. & Conrad, R. S. Branched-chain amino acid catabolism in bacteria. Bacteriol. Rev. 40, 42-54 (1976).
60. Allison, M. J. Production of branched-chain volatile fatty acids by certain anaerobic bacteria. Appl. Environ. Microbiol. 35, 872-877 (1978).
61. Martens, E. C. et al. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol. 9, e1001221 (2011).
62. Yin, Y. et al. DbCAN: a web resource for automated carbohydrate-active enzyme annotation. Nucleic Acids Res. 40, 445-451 (2012).
63. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMB net J. 17, 10-12 (2011).
64. Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19, 455-477 (2012).
65. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068-2069 (2014).